Cargando…
Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
BACKGROUND: Dendritic cells (DCs) are central for the initiation and regulation of innate and adaptive immunity in the tumor microenvironment. As such, many kinds of DC-targeted vaccines have been developed to improve cancer immunotherapy in numerous clinical trials. Targeted delivery of antigens an...
Autores principales: | Huang, Lanxiang, Rong, Yuan, Tang, Xuan, Yi, Kezhen, Qi, Peng, Hou, Jinxuan, Liu, Weihuang, He, Yuan, Gao, Xing, Yuan, Chunhui, Wang, Fubing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831689/ https://www.ncbi.nlm.nih.gov/pubmed/35148751 http://dx.doi.org/10.1186/s12943-022-01515-x |
Ejemplares similares
-
Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
por: Huang, Lanxiang, et al.
Publicado: (2021) -
COVID-19: advance in laboratory diagnostic strategy and technology
por: Yi, Kezhen, et al.
Publicado: (2021) -
Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications
por: Zhang, Qian, et al.
Publicado: (2020) -
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies
por: Huang, Lanxiang, et al.
Publicado: (2021) -
In Situ Vaccination with Mitochondria‐Targeting Immunogenic Death Inducer Elicits CD8(+) T Cell‐Dependent Antitumor Immunity to Boost Tumor Immunotherapy
por: Wang, Yuxiang, et al.
Publicado: (2023)